, whereas the incidences of progressive obesity and hypertension were much lower in patients in the CD + PRL group than in patients in the CD group (P = 0.009 and P < 0.001, resp). The gene discussed is PRL; the disease is obesity due to melanocortin 4 receptor deficiency.